Pancreatic resection for metastasis from renal cell carcinoma: A single institution experience and meta-analysis of survival outcomes
Pancreatology · 2024
DOI: 10.1016/j.pan.2023.11.014 ↗Kurz gefasst
Metaanalyse in der Zeitschrift Pancreatology, 2024. Verfasst von Shahin Hajibandeh und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hepatobiliary and Pancreatic Surgery, Royal Stoke University Hospital, University Hospitals of North Midlands NHS Trust, Stoke-on-Trent…. Hauptthemen laut MEDLINE: Carcinoma, Renal Cell, Kidney Neoplasms, Pancreatic Neoplasms. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 43 Literaturangaben.
Abstract (Originalsprache)
AIMS: To evaluate short-term clinical and long-term survival outcomes of pancreatic resection for pancreatic metastasis from renal cell carcinoma (RCC). METHODS: A retrospective evaluation of patients undergoing pancreatic resection for metastasis from RCC over a 12-years period was conducted. Furthermore, a systematic search of electronic data sources and bibliographic reference lists were conducted to identify studies investigating the same clinical question. Short-term clinical and long-term survival outcomes were evaluated. Kaplan-Meier survival plots were constructed for survival outcomes. Cox-proportional regression analysis was performed to determine factors associated with survival. Finally, meta-analysis of survival outcomes was conducted using random-effects modelling. RESULTS: Eighteen patients underwent pancreatic resections for RCC pancreatic metastasis within the study period. The mean age of the included patients was 63.8 ± 8.0 years. There were 10(55.6 %) male and 8(44.4 %) female patients. Pancreatectomy was associated with 4(25.0 %) Clavien-Dindo (C-D) I, 5(31.3 %) C-D II, and 7(43.7 %) C-D III complications, 7(38.8 %) pancreatic fistula, 3(16.7 %) post-pancreatectomy acute pancreatitis, 1(5.6 %) delayed gastric emptying, and 1(5.6 %) chyle leak. The mean length of hospital stay was 18 ± 16.3 days. The median survival was 64 months (95 % CI 60-78). The 3-and 5-year disease-free survival rates were 83.3 % and 55.5 %, respectively. The 3-and 5-year survival rates were 100 % and 55.6 %, respectively. The pooled analyses of 553 patients demonstrated 3-and 5-year survival rates of 77.6 % and 60.7 %, respectively. CONCLUSIONS: Pancreatectomy for RCC metastasis is associated with acceptable short-term clinical and promising long-term survival outcomes. Considering the rarity of the entity, escalation of level of evidence in this context is challenging.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Hepatobiliary and Pancreatic Surgery, Royal Stoke University Hospital, University Hospitals of North Midlands NHS Trust, Stoke-on-Trent, United Kingdom. Electronic address: shahin_hajiabndeh@yahoo.com.
- Department of Hepatobiliary and Pancreatic Surgery, University Hospital of Wales, Cardiff, United Kingdom.
- Department of Hepatobiliary and Pancreatic Surgery, Royal Stoke University Hospital, University Hospitals of North Midlands NHS Trust, Stoke-on-Trent, United Kingdom.
Zitieren
APA
Hajibandeh, S., Hajibandeh, S., Romman, S., Ghassemi, N., Evans, D., Laing, R. W., Durkin, D., & Athwal, T. S. (2024). Pancreatic resection for metastasis from renal cell carcinoma: A single institution experience and meta-analysis of survival outcomes. Pancreatology. https://doi.org/10.1016/j.pan.2023.11.014
Vancouver
Hajibandeh S, Hajibandeh S, Romman S, Ghassemi N, Evans D, Laing RW, et al. Pancreatic resection for metastasis from renal cell carcinoma: A single institution experience and meta-analysis of survival outcomes. Pancreatology. 2024. doi:10.1016/j.pan.2023.11.014
BibTeX
@article{Hajibandeh2024,
author = {Hajibandeh, Shahin and Hajibandeh, Shahab and Romman, Saleh and Ghassemi, Nader and Evans, Daisy and Laing, Richard W and Durkin, Damien and Athwal, Tejinderjit S},
title = {Pancreatic resection for metastasis from renal cell carcinoma: A single institution experience and meta-analysis of survival outcomes},
journal = {Pancreatology},
year = {2024},
doi = {10.1016/j.pan.2023.11.014}
}
EUVIMED